Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Apperley

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Best Practice & Research. Clinical Haematology|December 5, 2009
CML in pregnancy and childhoodJane Apperley
Journal of the National Comprehensive Cancer Network : JNCCN|November 26, 2009
Issues of imatinib and pregnancy outcomeJane Apperley
Future Oncology (London, England)|February 25, 2011
Nilotinib: evaluation and analysis of its role in chronic myeloid leukemiaPaula Garland, Jane Apperley
Current Opinion in Oncology|November 29, 2007
State-of-the-art in the treatment of chronic myeloid leukaemiaDragana Milojkovic, Jane Apperley
The New England Journal of Medicine|September 21, 2002
Major radiation exposureRay Powles, Jane Apperley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid LeukemiaDragana Milojkovic, Jane Apperley
Current Hematologic Malignancy Reports|December 21, 2019
What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?Robert Peter Gale, Jane Apperley
Experimental Hematology|August 30, 2008
Assessment of the role of timing of second transplantation in multiple myeloma by multistate modelingSimona Iacobelli, Jane Apperley, Curly Morris
Expert Review of Anticancer Therapy|May 10, 2005
Personalized medical treatment strategies for patients with chronic myeloid leukemiaCatherine Burton, David Marin, Jane Apperley
Leukemia & Lymphoma|February 7, 2013
Imatinib and chronic myeloid leukemia: close to the boneEvangelos Terpos, Jane Apperley, Dragana Milojkovic
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Best Practice & Research. Clinical Haematology|December 5, 2009
CML in pregnancy and childhoodJane Apperley
Journal of the National Comprehensive Cancer Network : JNCCN|November 26, 2009
Issues of imatinib and pregnancy outcomeJane Apperley
Future Oncology (London, England)|February 25, 2011
Nilotinib: evaluation and analysis of its role in chronic myeloid leukemiaPaula Garland, Jane Apperley
Current Opinion in Oncology|November 29, 2007
State-of-the-art in the treatment of chronic myeloid leukaemiaDragana Milojkovic, Jane Apperley
The New England Journal of Medicine|September 21, 2002
Major radiation exposureRay Powles, Jane Apperley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid LeukemiaDragana Milojkovic, Jane Apperley
Current Hematologic Malignancy Reports|December 21, 2019
What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?Robert Peter Gale, Jane Apperley
Experimental Hematology|August 30, 2008
Assessment of the role of timing of second transplantation in multiple myeloma by multistate modelingSimona Iacobelli, Jane Apperley, Curly Morris
Expert Review of Anticancer Therapy|May 10, 2005
Personalized medical treatment strategies for patients with chronic myeloid leukemiaCatherine Burton, David Marin, Jane Apperley
Leukemia & Lymphoma|February 7, 2013
Imatinib and chronic myeloid leukemia: close to the boneEvangelos Terpos, Jane Apperley, Dragana Milojkovic
Pageof 12